The World of Health & Medicine News

Lifetime toll: 840 million women faced partner or sexual violence

Lifetime toll: 840 million women faced partner or sexual violence

Violence against women remains one of the world’s most persistent and under-addressed human rights crises, with very little progress in two decades, according to a landmark report released today by the World Health Organization (WHO) and UN partners.

Nearly 1 in 3 women – estimated 840 million globally – have experienced partner or sexual violence during their lifetime, a figure that has barely changed since 2000. In the last 12 months alone, 316 million women – 11% of those aged 15 or older – were subjected to physical or sexual violence by an intimate partner. Progress on reducing intimate partner violence has been painfully slow with only 0.2% annual decline over the past two decades.

For the first time, the report includes national and regional estimates of sexual violence by someone other than a partner. It finds 263 million women have experienced non-partner sexual violence since age 15, a figure experts caution is significantly under-reported due to stigma and fear.

“Violence against women is one of humanity’s oldest and most pervasive injustices, yet still one of the least acted upon,” said Dr Tedros Adhanom Ghebreyesus, WHO Director-General. “No society can call itself fair, safe or healthy while half its population lives in fear. Ending this violence is not only a matter of policy; it is a matter of dignity, equality and human rights. Behind every statistic is a woman or girl whose life has been forever altered.  Empowering women and girls is not optional, it’s a prerequisite for peace, development and health. A safer world for women is a better world for everyone.”

spot_img

Explore more

spot_img

What Happens to Your Blood Sugar When You Eat Pomegranates on...

What Happens to Your Blood Sugar When You Eat Pomegranates on an Empty Stomach Pomegranates, like all fruits, contain carbohydrates that are broken down into...

Bayer reports positive results for blood thinner after 2023 setback

Bayer reports positive results for blood thinner after 2023 setback German pharma company Bayer reported positive study results for its anticoagulant asundexian on Sunday, two...

US FDA approves Novartis’ gene therapy for rare muscle disorder

US FDA approves Novartis' gene therapy for rare muscle disorder The U.S. Food and Drug Administration has approved Novartis' (NOVN.S), opens new tab gene therapy for...

New, effective anti-malaria drug could help fight rising resistance, says Novartis

New, effective anti-malaria drug could help fight rising resistance, says Novartis  A new antimalarial drug developed by Novartis (NOVN.S), opens new tab is as effective as existing...

Poor Oral Health Linked to Hidden Brain Damage

Poor Oral Health Linked to Hidden Brain Damage New research suggests that gum disease may be linked to subtle but measurable changes in the brain. Older...

US CDC adopts Kennedy’s anti-vaccine views on recast website

US CDC adopts Kennedy's anti-vaccine views on recast website The U.S. Centers for Disease Control and Prevention recast the vaccine safety section of its website...

Elanco’s Drug Gets Emergency Nod to Treat Deadly Flesh-Eating Parasite in...

Elanco's Drug Gets Emergency Nod to Treat Deadly Flesh-Eating Parasite in Cats The U.S. Food and Drug Administration on Friday authorized emergency use of Elanco...

High-stakes Novo Nordisk Alzheimer’s studies could yield answers on GLP-1 benefit

High-stakes Novo Nordisk Alzheimer's studies could yield answers on GLP-1 benefit Studies from Novo Nordisk (NOVOb.CO), opens new tab due early next month will give the strongest...